RIGHT-Net: Right Heart International NETwork During Exercise in Different Clinical Conditions

Sponsor
Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona (Other)
Overall Status
Recruiting
CT.gov ID
NCT03041337
Collaborator
(none)
1,000
1
115.1
8.7

Study Details

Study Description

Brief Summary

The aim of this registry will be to compare the pathophysiological response of the morphology and function of the right heart and pulmonary circulation assessed with resting and stress-echocardiography in patients with various cardiovascular diseases, to compare them to healthy individuals. The physiological response in healthy individuals as well as elite athletes, defined as athletes participating at national and international competitions, will also be evaluated. Patients will be enrolled both prospectively as well as retrospectively and the will be evaluated by resting and stress echocardiography, which are part of the routine clinical practice.

All clinical outcome measures will be collected as part of routine examinations. The measurements will include systolic and diastolic pump function of the right and left ventricles and other echocardiographic parameters. Moreover, a comparison of these parameters among different groups will be performed. Other optional assessments will include: exercise capacity assessed with 6-minute walking distance, World Health Organization functional class (WHO functional class), peak oxygen uptake assessed by spiroergometry. Patients will be evaluated at baseline and each year with the aforementioned procedures according to the sites clinical routine.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: stress echocardiography

Detailed Description

Patients will be evaluated with a routinely performed resting and stress echocardiography. Moreover, physical examination and ECG will be performed and past medical history will be collected. Optional procedures comprise of quality of life assessment (SF-36 questionnaire), six minute walking distance (6MWD), cardiopulmonary exercise testing (CPET), routine laboratory including biochemical work-up.

Comparison among different cohorts of patients with regards to right heart morphology and function at rest, assessed during a routinely performed resting and stress echography. The following parameters will be evaluated:

  • Right ventricular (RV) diameters

  • RV free wall thickness

  • End-diastolic and end-systolic left ventricular volumes and ejection fraction

  • Right atrial (RA) area

  • End-diastolic and end-systolic RV area and % shortening of the areas of the right ventricle

  • Tricuspid regurgitation velocity (TRV) and severity

  • Tricuspid annular plane systolic excursion (TAPSE)

  • Inferior vena cava diameter and % of collapsibility

  • TAPSE at peak exercise and after 5 minutes recovery

  • TRV at peak exercise and after 5 minutes recovery

  • RV end-diastolic and end-systolic area and % shortening of the areas at peak exercise and after 5 minutes recovery

  • RA area at peak exercise and after 5 minutes recovery

  • Left ventricular end-diastolic and end-systolic volume and ejection fraction at peak exercise and after 5 minutes recovery

  • Left ventricular eccentricity index at peak exercise and after 5 minutes recovery

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
1000 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Morphological and Functional Response of the Right Heart and Pulmonary Circulation
Actual Study Start Date :
Jun 1, 2015
Anticipated Primary Completion Date :
Jan 1, 2020
Anticipated Study Completion Date :
Jan 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Healthy subjects

Cohort of patients referred to our echocardiography laboratory to work assessment procedures and without any cardiovascular risk factor. They will underwent stress echocardiography.

Diagnostic Test: stress echocardiography
stress echocardiography will be performed in accordance with the current guidelines on a variable load 45° cycle ergometer with an incremental workload of 25 W every 2 minutes up to the symptom-limited maximal tolerated workload. Echocardiographic measurements will be acquired at baseline, at peak exercise and during recovery of 5 minutes. The electrocardiogram and blood pressure will be monitored at each workload. Termination criteria and / or positive test criteria for inducible myocardial ischemia will follow the current recommendations

cardio-respiratory diseases

patients with any possible cardiovascular and respiratory condition. They will underwent stress echocardiography.

Diagnostic Test: stress echocardiography
stress echocardiography will be performed in accordance with the current guidelines on a variable load 45° cycle ergometer with an incremental workload of 25 W every 2 minutes up to the symptom-limited maximal tolerated workload. Echocardiographic measurements will be acquired at baseline, at peak exercise and during recovery of 5 minutes. The electrocardiogram and blood pressure will be monitored at each workload. Termination criteria and / or positive test criteria for inducible myocardial ischemia will follow the current recommendations

Outcome Measures

Primary Outcome Measures

  1. Right Ventricle contractile reserve [ten years]

    Difference of tricuspid regurgitation velocity at rest to peak exercise (m/s)

Secondary Outcome Measures

  1. All-cause Mortality [ten years]

    All cause of mortality

  2. Cardiovascular Mortality [ten years]

    all cardiovascular mortality

  3. RV internal end-diastolic diameters [ten years]

    measurement of basal and midcavity RV internal end-diastolic diameters from the four-chamber view in mm

  4. tricuspid annular plane systolic excursion (TAPSE) [ten years]

    tricuspid annular plane systolic excursion (TAPSE) determined in M-mode in mm

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Written informed consent

  • Males and females ≥ 18 years' old

  • Ability to understand study-specific design and procedures and provide informed consent to the study

Exclusion Criteria:
  • Inability to perform exercise stress test

  • Active smoker

  • Pregnancy and/or lactation

  • Active malignancy

  • End-stage renal disease requiring dialysis

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cardiology and Coronary Care Unit Cava de' Tirreni Salerno Italy 84019

Sponsors and Collaborators

  • Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona

Investigators

  • Study Chair: Eduardo Bossone, Azienda Universitaria Ospedaliera "S. Giovanni e Ruggi d'Aragona"

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Eduardo Bossone, Director of Cardiology and Coronary Care Unit, Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona
ClinicalTrials.gov Identifier:
NCT03041337
Other Study ID Numbers:
  • RIGHT-Net
First Posted:
Feb 2, 2017
Last Update Posted:
Feb 2, 2017
Last Verified:
Jan 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 2, 2017